Low-dose rituximab should be used for treating MS in resource-limited settings: No
FJ Mateen - Multiple Sclerosis Journal, 2022 - journals.sagepub.com
While patients with multiple sclerosis (MS) in most wealthy settings have access to more
than 20 diseasemodifying therapies (DMTs), patients in resourcelimited settings often have …
than 20 diseasemodifying therapies (DMTs), patients in resourcelimited settings often have …